Clinical trial

Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus

NCT01374854

Study summary

ClinicalTrials.gov

Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention Umbilical mesenchymal stem cell (UC-MSCs) infusion Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention traditional therapy Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE1 / PHASE2

Conditions

Type 1 Diabetes Mellitusverified · MONDO: type 1 diabetes mellitus

Interventions

Umbilical mesenchymal stem cell (UC-MSCs) infusionBIOLOGICAL

traditional therapyDRUG

Sponsors & collaborators

Fuzhou General Hospitallead sponsor

Mapped research locations

FuzhouFujian, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01374854 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.